Beijing Tong Ren Tang Chinese Medicine Co Stock

Beijing Tong Ren Tang Chinese Medicine Co Equity 2024

Beijing Tong Ren Tang Chinese Medicine Co Equity

3.87 B HKD

Ticker

3613.HK

ISIN

HK0000145638

WKN

A1XDB1

In 2024, Beijing Tong Ren Tang Chinese Medicine Co's equity was 3.87 B HKD, a 7.27% increase from the 3.6 B HKD equity in the previous year.

Beijing Tong Ren Tang Chinese Medicine Co Aktienanalyse

What does Beijing Tong Ren Tang Chinese Medicine Co do?

Beijing Tong Ren Tang Chinese Medicine Co Ltd is one of the leading companies in the field of traditional Chinese medicine (TCM) and is headquartered in Beijing, China. The company was founded in 1669 and has a long history in the manufacturing of TCM products. The company has a versatile business model and is involved in various sectors. In addition to manufacturing TCM products, the company operates 30 retail stores in China and 24 internationally in countries such as the USA, Canada, Japan, and Singapore, to name a few. Tong Ren Tang also offers its products online and works with distributors and pharmacies worldwide. The company places great emphasis on quality and has invested in state-of-the-art production facilities in recent years to ensure the highest standards. Tong Ren Tang has not only improved TCM preparations but also produced a variety of dietary supplements, skincare products, herbal baths, and children's medications. TCM is a natural approach to treating diseases that dates back many centuries and is still popular among many people. Tong Ren Tang specializes in delivering TCM products of the highest quality. The products are manufactured under strict quality controls that ensure the purity and efficacy of the product. The company is known for its famous brand, "Tong Ren Tang," which is highly popular in China and around the world. Tong Ren Tang products are available in more than 50 countries worldwide and are appreciated by thousands of customers. In addition to their core competence in manufacturing TCM products and supplements, Tong Ren Tang has also developed other products, such as premium skincare products like Ginseng and Pearl Night Cream. To ensure effectiveness and safety, the company has been striving for centuries to achieve the highest standards by using high-quality and trusted raw materials. Tong Ren Tang is also committed to educating the public about the benefits of TCM and has conducted many radio advertisements and sponsored television shows through Pan-Asian channels in recent years. The company has also received various international awards and certifications such as GMP (Good Manufacturing Practice) and actively advocates for environmental protection and social responsibility. Overall, Beijing Tong Ren Tang is a unique company that seamlessly combines tradition and modern technology to produce top-quality TCM products. Tong Ren Tang's commitment to quality, effectiveness, and safety, as well as its promotion of the TCM industry, has helped expand understanding and access to TCM products worldwide. Beijing Tong Ren Tang Chinese Medicine Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Beijing Tong Ren Tang Chinese Medicine Co's Equity

Beijing Tong Ren Tang Chinese Medicine Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Beijing Tong Ren Tang Chinese Medicine Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Beijing Tong Ren Tang Chinese Medicine Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Beijing Tong Ren Tang Chinese Medicine Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Beijing Tong Ren Tang Chinese Medicine Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Beijing Tong Ren Tang Chinese Medicine Co stock

What is the equity of Beijing Tong Ren Tang Chinese Medicine Co this year?

Beijing Tong Ren Tang Chinese Medicine Co has equity of 3.87 B HKD this year.

What was the equity of Beijing Tong Ren Tang Chinese Medicine Co compared to the previous year?

The equity of Beijing Tong Ren Tang Chinese Medicine Co has increased/decreased by 7.27% increased compared to the previous year.

What impact does a high equity have on investors of Beijing Tong Ren Tang Chinese Medicine Co?

A high equity is advantageous for investors of Beijing Tong Ren Tang Chinese Medicine Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Beijing Tong Ren Tang Chinese Medicine Co?

A low equity can be a risk for investors of Beijing Tong Ren Tang Chinese Medicine Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Beijing Tong Ren Tang Chinese Medicine Co affect the company?

An increase in equity of Beijing Tong Ren Tang Chinese Medicine Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Beijing Tong Ren Tang Chinese Medicine Co affect the company?

A reduction in equity of Beijing Tong Ren Tang Chinese Medicine Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Beijing Tong Ren Tang Chinese Medicine Co?

Some factors that can affect the equity of Beijing Tong Ren Tang Chinese Medicine Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Beijing Tong Ren Tang Chinese Medicine Co so important for investors?

The equity of Beijing Tong Ren Tang Chinese Medicine Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Beijing Tong Ren Tang Chinese Medicine Co take to change the equity?

To change equity, Beijing Tong Ren Tang Chinese Medicine Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Beijing Tong Ren Tang Chinese Medicine Co pay?

Over the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co paid a dividend of 0.66 HKD . This corresponds to a dividend yield of about 7.58 %. For the coming 12 months, Beijing Tong Ren Tang Chinese Medicine Co is expected to pay a dividend of 0.71 HKD.

What is the dividend yield of Beijing Tong Ren Tang Chinese Medicine Co?

The current dividend yield of Beijing Tong Ren Tang Chinese Medicine Co is 7.58 %.

When does Beijing Tong Ren Tang Chinese Medicine Co pay dividends?

Beijing Tong Ren Tang Chinese Medicine Co pays a quarterly dividend. This is distributed in the months of November, June, July, July.

How secure is the dividend of Beijing Tong Ren Tang Chinese Medicine Co?

Beijing Tong Ren Tang Chinese Medicine Co paid dividends every year for the past 13 years.

What is the dividend of Beijing Tong Ren Tang Chinese Medicine Co?

For the upcoming 12 months, dividends amounting to 0.71 HKD are expected. This corresponds to a dividend yield of 8.19 %.

In which sector is Beijing Tong Ren Tang Chinese Medicine Co located?

Beijing Tong Ren Tang Chinese Medicine Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Tong Ren Tang Chinese Medicine Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Tong Ren Tang Chinese Medicine Co from 6/24/2024 amounting to 0.33 HKD, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Beijing Tong Ren Tang Chinese Medicine Co pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Beijing Tong Ren Tang Chinese Medicine Co in the year 2023?

In the year 2023, Beijing Tong Ren Tang Chinese Medicine Co distributed 0.53 HKD as dividends.

In which currency does Beijing Tong Ren Tang Chinese Medicine Co pay out the dividend?

The dividends of Beijing Tong Ren Tang Chinese Medicine Co are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Beijing Tong Ren Tang Chinese Medicine Co

Our stock analysis for Beijing Tong Ren Tang Chinese Medicine Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Tong Ren Tang Chinese Medicine Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.